MICHAEL ANDERSON: Open Payments
NPI 1992285605 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,300 in 52 payments from 16 companies in 2025. Trend: 2023 $238 · 2024 $1,062 · 2025 $1,300
Food & beverage: $1,036Education: $264
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $276 |
| Janssen Biotech, Inc. | 9 | $176 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $125 |
| LEO Pharma Inc. | 6 | $120 |
| ABBVIE INC. | 5 | $115 |
| Lilly USA, LLC | 3 | $79 |
| Incyte Corporation | 3 | $76 |
| UCB, Inc. | 3 | $69 |
| PFIZER INC. | 2 | $55 |
| Galderma Laboratories, L.P. | 3 | $45 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, OPZELURA, ANZUPGO, Bimzelx, CIBINQO, TALTZ.
Industry payments across NV — which companies pay providers there.
